News & info about embecta (formerly part of BD) a global #medtech company singularly focused on #DiabetesCare. BD is the manufacturer of advertised products.
We’re excited to host our inaugural Analyst and Investor Day on Thursday, May 22, to showcase our strategic vision and long-range financial plan. Register at investorday.embecta.com.
Are your patients with #diabetes staying vigilant about #kidneycare? These #WorldKidneyDay reminders can help them keep their kidney health top of mind.
Come say hello to us tomorrow at #JPM2025! Our President and CEO Dev Kurdikar will be presenting at 7:30 a.m. PT / 10:30 a.m. ET.
Not attending? Listen to the webcast here: bit.ly/4fWJOJJ
We're looking forward to presenting at the 43rd annual J.P. Morgan Healthcare Conference.
Read more about our participation at #JPM2025 in our release: investors.embecta.com/news-r…
We’re proud to partner with @embecta. Our deep expertise in the life sciences & healthcare sectors alongside our capabilities in data and technologies enables embecta’s vision to make a meaningful impact in the healthcare sector. bit.ly/4fsSLf5
Today is the day! We're excited to start #ATTD2024 with our Industry Symposium. Join us for insights into exciting #diabetes technology research. Elevate your diabetes care knowledge with us today!